ASSOCIATION OF PROMOTER REGION POLYMORPHISMS OF INTERLEUKIN-10 GENE WITH SUSCEPTIBILITY TO COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
- PMID: 30540096
- DOI: 10.1590/S0004-2803.201800000-66
ASSOCIATION OF PROMOTER REGION POLYMORPHISMS OF INTERLEUKIN-10 GENE WITH SUSCEPTIBILITY TO COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
Abstract
Background: Several epidemiological studies have investigated the association of promoter region polymorphisms of Interleukin-10 (IL-10) gene with colorectal cancer (CRC), while the conclusion is still conflicting and inconclusive.
Objective: We conducted this meta-analysis to evaluate the association of promoter region polymorphisms of IL-10 with CRC.
Methods: Eligible articles were identified by a search of several bibliographic databases for the period up to March 15, 2018. The strength of the association was measured by odd ratios with 95% confidence intervals.
Results: A total of 28 case-control studies with 5,647 CRC cases and 6,908 controls were selected, including 14 studies for IL-10 -1082A>G (rs1800896) polymorphism (2,702 cases and 3,649 controls), eleven studies for -592C>A (rs1800872) polymorphism (3,259 cases and 4,992 controls), and three studies for -819T>C (rs1800871) polymorphism (477 cases and 544 controls). By pooling all eligible studies, we found that the IL-10 -1082A>G and -592C>A polymorphisms were not associated with increased CRC risk in overall population. However, there was significant associations between the IL-10 -819T>C polymorphism and CRC susceptibility under the allele model (A vs G: OR=1.278, 95% CI 1.043-1.566, P=0.018) and the recessive model (AA vs AG+GG: OR=1.709, 95% CI 1.026-2.845, P=0.039).
Conclusion: In this meta-analysis we found that IL-10 -819T>C polymorphism was associated with significantly increased risk of CRC; while the IL-10 -1082A>G and -592C>A polymorphisms were not associated with CRC risk. The IL-10 -819T>C polymorphism may be important as suspected predictive factor of CRC occurrence.
Similar articles
-
Association of IL-4 and IL-10 Polymorphisms With Preterm Birth Susceptibility: A Systematic Review and Meta-Analysis.Front Immunol. 2022 Jul 4;13:917383. doi: 10.3389/fimmu.2022.917383. eCollection 2022. Front Immunol. 2022. PMID: 35860261 Free PMC article.
-
Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.Eur J Cancer Prev. 2017 Nov;26(6):476-490. doi: 10.1097/CEJ.0000000000000370. Eur J Cancer Prev. 2017. PMID: 28538040
-
IL-10 -1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis.Onco Targets Ther. 2016 Oct 7;9:6083-6091. doi: 10.2147/OTT.S118481. eCollection 2016. Onco Targets Ther. 2016. PMID: 27785055 Free PMC article.
-
Association of Interleukin-10 Polymorphisms with Susceptibility to Colorectal Cancer and Gastric Cancer: an Updated Meta-analysis Based on 106 Studies.J Gastrointest Cancer. 2022 Dec;53(4):1066-1082. doi: 10.1007/s12029-021-00685-z. Epub 2021 Oct 25. J Gastrointest Cancer. 2022. PMID: 34694592 Review.
-
Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.Genet Mol Res. 2012 Sep 25;11(3):3389-97. doi: 10.4238/2012.September.25.7. Genet Mol Res. 2012. PMID: 23079832
Cited by
-
Hardy-Weinberg Equilibrium in Meta-Analysis Studies and Large-Scale Genomic Sequencing Era.Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2229-2235. doi: 10.31557/APJCP.2024.25.7.2229. Asian Pac J Cancer Prev. 2024. PMID: 39068553 Free PMC article. Review.
-
Association of IL-12B rs3212227 and IL-6 rs1800795 Polymorphisms with Susceptibility to Cervical Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2020 May 1;21(5):1197-1206. doi: 10.31557/APJCP.2020.21.5.1197. Asian Pac J Cancer Prev. 2020. PMID: 32458622 Free PMC article.
-
A comprehensive integration of data on the association of ITPKC polymorphisms with susceptibility to Kawasaki disease: a meta-analysis.BMC Med Genomics. 2025 Mar 20;18(1):56. doi: 10.1186/s12920-025-02121-8. BMC Med Genomics. 2025. PMID: 40114120 Free PMC article.
-
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology.Expert Rev Mol Med. 2024 Jan 8;26:e1. doi: 10.1017/erm.2023.26. Expert Rev Mol Med. 2024. PMID: 38186186 Free PMC article. Review.
-
Ethical Considerations and Equipoise in Cancer Surgery.Indian J Surg Oncol. 2024 Sep;15(Suppl 3):363-373. doi: 10.1007/s13193-024-02023-8. Epub 2024 Jul 12. Indian J Surg Oncol. 2024. PMID: 39328740 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical